Lv11
10 积分 2021-09-20 加入
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
5小时前
待确认
Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial – the PRODIGE 22 - ECKINOXE trial
9个月前
已完结
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial
1年前
已完结
Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial
1年前
已完结
Lynch syndrome, molecular mechanisms and variant classification
1年前
已完结
Anal Cancer: Emerging Standards in a Rare Disease
2年前
已完结
Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer
2年前
已完结
Overcoming acquired MET amplification after encorafenib-cetuximab in BRAF-V600E mutated colorectal cancer
2年前
已完结
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAFV600E-Mutant Metastatic Colorectal Cancer
2年前
已完结
Targeting Mutated KRAS Genes to Treat Solid Tumours
2年前
已完结
麻疹疫苗株Schwarz反向遗传系统的建立
皖公网安备34019202002308
